Back to User profile » Dr Tsukasa Koyama

Papers published by Dr Tsukasa Koyama:


Long-term administration of escitalopram in patients with social anxiety disorder in Japan

Asakura S, Hayano T, Hagino A, Koyama T

Neuropsychiatric Disease and Treatment 2016, 12:1817-1825

Published Date: 22 July 2016

Efficacy comparison of duloxetine and SSRIs at doses approved in Japan

Harada E, Schacht A, Koyama T, Marangell LB, Tsuji T, Escobar R

Neuropsychiatric Disease and Treatment 2015, 11:115-123

Published Date: 12 January 2015

Effect of the coadministration of citalopram with mirtazapine or atipamezole on rat contextual conditioned fear

Masuda T, Inoue T, An Y, Takamura N, Nakagawa S, Kitaichi Y, Koyama T, Kusumi I

Neuropsychiatric Disease and Treatment 2014, 10:289-295

Published Date: 11 February 2014

Selegiline remarkably improved stage 5 treatment-resistant major depressive disorder: a case report

Kitaichi Y, Inoue T, Mitsui N, Nakagawa S, Kameyama R, Hayashishita Y, Shiga T, Kusumi I, Koyama T

Neuropsychiatric Disease and Treatment 2013, 9:1591-1594

Published Date: 17 October 2013

Differences between bipolar and unipolar depression on Rorschach testing

Kimura H, Osaki A, Kawashima R, Inoue T, Nakagawa S, Suzuki K, Asakura S, Tanaka T, Kitaichi Y, Masui T, Kitagawa N, Kako Y, Abekawa T, Kusumi I, Yamanaka H, Denda K, Koyama T

Neuropsychiatric Disease and Treatment 2013, 9:619-627

Published Date: 7 May 2013

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression

Kamijima K, Hashimoto S, Nagayoshi E, Koyama T

Neuropsychiatric Disease and Treatment 2013, 9:555-565

Published Date: 26 April 2013

Effect of triiodothyronine (T3) augmentation of acute milnacipran administration on monoamine levels: an in vivo microdialysis study in rats

Kitaichi Y, Inoue T, Nakagawa S, Boku S, Kato A, Kusumi I, Koyama T

Neuropsychiatric Disease and Treatment 2012, 8:501-507

Published Date: 30 October 2012